Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.
Lancet Diabetes Endocrinol. 2017 Apr;5(4):251-260. doi: 10.1016/S2213-8587(17)30013-X. Epub 2017 Jan 17.
Lancet Diabetes Endocrinol. 2017.
PMID: 28110911
Clinical Trial.
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
Ahrén B, Masmiquel L, Kumar H, Sargin M, Karsbøl JD, Jacobsen SH, Chow F.
Ahrén B, et al. Among authors: karsbol jd.
Lancet Diabetes Endocrinol. 2017 May;5(5):341-354. doi: 10.1016/S2213-8587(17)30092-X. Epub 2017 Apr 3.
Lancet Diabetes Endocrinol. 2017.
PMID: 28385659
Clinical Trial.
Item in Clipboard
No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial.
Hegedüs L, Sherman SI, Tuttle RM, von Scholten BJ, Rasmussen S, Karsbøl JD, Daniels GH; LEADER Publication Committee on behalf of the LEADER Trial Investigators.
Hegedüs L, et al. Among authors: karsbol jd.
Diabetes Care. 2018 Mar;41(3):620-622. doi: 10.2337/dc17-1956. Epub 2017 Dec 26.
Diabetes Care. 2018.
PMID: 29279300
Clinical Trial.
Item in Clipboard
[Low mortality following salicylic poisoning].
Karsbøl JD, Jørgensen HL, Dalhoff K.
Karsbøl JD, et al.
Ugeskr Laeger. 2010 Sep 13;172(37):2541-6.
Ugeskr Laeger. 2010.
PMID: 20836965
Danish.
Item in Clipboard
Cite
Cite